Abstract
Doravirine (DOR), which is currently in a phase 3 clinical trial, is a novel human immunodeficiency type 1 virus (HIV-1) nonnucleoside reverse transcriptase inhibitor (NNRTI). DOR exhibits potent antiviral activity against wild-type virus and K103N, Y181C, and K103N/Y181C mutant viruses, with 50% inhibitory concentrations (IC50s) of 12, 21, 31, and 33 nM, respectively, when measured in 100% normal human serum (NHS). To assess the potential for DOR to suppress NNRTI-associated and rilpivirine (RPV)-specific mutants at concentrations achieved in the clinic setting, inhibitory quotients (IQs) were calculated by determining the ratio of the clinical trough concentration over the antiviral IC50for each virus with DOR and RPV and efavirenz (EFV). DOR displayed IQs of 39, 27, and 25 against the K103N, Y181C, and K103N/Y181C mutants, respectively. In contrast, RPV exhibited IQs of 4.6, 1.4, and 0.8, and EFV showed IQs of 2.5, 60, and 1.9 against these viruses, respectively. DOR also displayed higher IQs than those of RPV and EFV against other prevalent NNRTI-associated mutants, with the exception of Y188L. Both DOR and EFV exhibited higher IQs than RPV when analyzed with RPV-associated mutants. Resistance selections were conducted with...Continue Reading
References
Mar 27, 1998·The New England Journal of Medicine·F J PalellaS D Holmberg
Aug 8, 1998·The New England Journal of Medicine·S H MichaelsP Kissinger
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B M SadlerD S Stein
Dec 25, 2002·Antimicrobial Agents and Chemotherapy·Ann HsuEugene Sun
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Véronique JolyFrançoise Brun-Vezinet
Nov 2, 2005·AIDS·Michael F SchneiderAlvaro Muñoz
Dec 6, 2005·AIDS·Deenan PillayUNKNOWN CASCADE Virology Collaboration
Mar 21, 2008·Journal of Virology·Susan J LittleDouglas D Richman
Aug 1, 2008·PLoS Medicine·Jeffrey A JohnsonWalid Heneine
Dec 18, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karin J MetznerMatthias Cavassini
Mar 18, 2009·Antimicrobial Agents and Chemotherapy·Ming-Tain LaiMichael D Miller
Apr 18, 2009·Current Opinion in HIV and AIDS·Charles la Porte
Aug 20, 2011·AIDS Research and Human Retroviruses·Julie E MyersKaren Brudney
Sep 1, 2011·AIDS Research and Human Retroviruses·Toshibumi TaniguchiEdgar Turner Overton
Nov 10, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Laurence RimskyGaston Picchio
Feb 9, 2012·Antimicrobial Agents and Chemotherapy·Carlos ZalaDouglas Mayers
Mar 7, 2012·Antimicrobial Agents and Chemotherapy·Meiqing LuMing-Tain Lai
Sep 12, 2012·Antimicrobial Agents and Chemotherapy·Edward P AcostaChristos J Petropoulos
Oct 23, 2013·HIV Clinical Trials·Anthony M MillsAndrew K Cheng
Jan 1, 2014·Antimicrobial Agents and Chemotherapy·Ming-Tain LaiMichael D Miller
Nov 12, 2014·Antimicrobial Agents and Chemotherapy·Meizhen FengMing-Tain Lai
Apr 8, 2015·PLoS Medicine·Soo-Yon RheeRobert W Shafer
Jun 6, 2015·Clinical Pharmacology and Therapeutics·L DickinsonUNKNOWN ENCORE1 Study Group
Citations
Sep 27, 2016·Viruses·Ming-Tain LaiMichael D Miller
Mar 21, 2018·Expert Opinion on Pharmacotherapy·Margaret R CaplanKatya C Corado
Mar 21, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Rosa I SanchezSauzanne G Khalilieh
Oct 14, 2017·The Journal of Antimicrobial Chemotherapy·Ming-Tain LaiRoman A Melnyk
Jun 13, 2018·Antimicrobial Agents and Chemotherapy·Wendy AnkromSauzanne G Khalilieh
Aug 4, 2018·The Annals of Pharmacotherapy·Jamielynn C Sebaaly, Denise Kelley
Nov 23, 2016·Antimicrobial Agents and Chemotherapy·Ka Lai YeeSauzanne G Khalilieh
Oct 21, 2018·Drugs·Emma D Deeks
Nov 27, 2018·The Journal of Antimicrobial Chemotherapy·Cathia SoulieAnne-Geneviève Marcelin
Feb 13, 2019·Antimicrobial Agents and Chemotherapy·Kelly BleasbyRosa I Sanchez
Feb 13, 2019·Antimicrobial Agents and Chemotherapy·Ka Lai YeeLarissa Wenning
Feb 21, 2019·Antimicrobial Agents and Chemotherapy·Sauzanne G KhaliliehMarian Iwamoto
Feb 21, 2019·Antimicrobial Agents and Chemotherapy·Wendy AnkromSauzanne Khalilieh
Aug 20, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Alexander WongHedy Teppler
Sep 11, 2019·Bioanalysis·Rajesh DesaiEric Woolf
Aug 17, 2019·The Annals of Pharmacotherapy·Sarah R BlevinsDavid B Cluck
Jan 25, 2020·The Journal of Antimicrobial Chemotherapy·Cathia SoulieAnne-Genevieve Marcelin
Feb 8, 2020·The Journal of Antimicrobial Chemotherapy·Carlos Guerrero-BeltránUNKNOWN CoRIS
Apr 10, 2020·Expert Opinion on Drug Metabolism & Toxicology·Megan NearyAdeniyi Olagunju
Jun 17, 2020·Expert Review of Clinical Pharmacology·Andrea GiacomelliStefano Rusconi
Aug 21, 2020·Clinical Drug Investigation·Sauzanne KhaliliehMarian Iwamoto
May 26, 2018·Current Opinion in HIV and AIDS·Marie-Alice Colombier, Jean-Michel Molina
Sep 6, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chloe OrkinUNKNOWN DRIVE-AHEAD Study Group
Aug 3, 2019·Infectious Diseases of Poverty·Emmanuel Ndashimye, Eric J Arts
Sep 27, 2019·Expert Opinion on Drug Metabolism & Toxicology·Yali WangGuangdi Li
Aug 8, 2019·Clinical Pharmacokinetics·Alison BoyleSaye Khoo
Sep 26, 2020·The Journal of Antimicrobial Chemotherapy·Francesco SaladiniMaurizio Zazzi
Apr 16, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Margaret JohnsonUNKNOWN DRIVE-SHIFT Study Group
Jun 18, 2020·Pharmaceuticals·Daniel M Himmel, Eddy Arnold
Sep 15, 2020·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Elizabeth Anne MartinErnest Asante-Appiah
Dec 19, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chloe OrkinHedy Teppler
Jan 23, 2021·Viruses·Mar ÁlvarezLuis Menéndez-Arias
Nov 20, 2019·The Lancet. HIV·Jean-Michel MolinaUNKNOWN DRIVE-FORWARD trial group
Feb 18, 2021·Chemical Society Reviews·Yue MaPeng Zhan
Oct 31, 2019·Global Health & Medicine·Manabu AokiHiroaki Mitsuya
Jan 29, 2021·Chemical Reviews·Maria E CilentoStefan G Sarafianos
Apr 16, 2021·The Journal of Antimicrobial Chemotherapy·Bluma G BrennerRéjean Thomas
May 5, 2021·Journal of the International AIDS Society·Kim SteegenLucia Hans
May 18, 2021·The Lancet. HIV·Jean-Michel MolinaPeter Sklar
Jun 22, 2021·Clinical Drug Investigation·Randolph P MatthewsMarian Iwamoto
Jun 22, 2021·The Journal of Antimicrobial Chemotherapy·Minh Patrick LêLaurent Mandelbrot
Oct 18, 2019·ACS Infectious Diseases·Carey HwangDaria J Hazuda
Aug 17, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Arturo CicculloSimona Di Giambenedetto
Feb 21, 2019·ACS Medicinal Chemistry Letters·Nicole PributStephen C Pelly
Sep 28, 2021·Antimicrobial Agents and Chemotherapy·Ernest Asante-AppiahJay A Grobler